{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:20:21Z","timestamp":1773663621956,"version":"3.50.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Economia y Competitividad, MINECO, Madrid, Spain","doi-asserted-by":"publisher","award":["BFU2014-53641-P"],"award-info":[{"award-number":["BFU2014-53641-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Spanish Ministerio de Economia y Competitividad, MINECO, Madrid, Spain","doi-asserted-by":"publisher","award":["BFU2017-85723-P"],"award-info":[{"award-number":["BFU2017-85723-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Junta de Extremadura","award":["GR15139"],"award-info":[{"award-number":["GR15139"]}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.neuropharm.2018.07.012","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T16:55:48Z","timestamp":1531155348000},"page":"163-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Methylene blue activates the PMCA activity and cross-interacts with amyloid \u03b2-peptide, blocking A\u03b2-mediated PMCA inhibition"],"prefix":"10.1016","volume":"139","author":[{"given":"Maria","family":"Berrocal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Corbacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Gutierrez-Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2887-7854","authenticated-orcid":false,"given":"Ana M.","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.07.012_bib1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0090-9556(25)08471-5","article-title":"Inhibition of (mono)amine oxidase activity and prevention of ifosfamide encephalopathy by methylene blue","volume":"24","author":"Aeschlimann","year":"1996","journal-title":"Drug Metab. Dispos."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2018.07.012_bib2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer's disease: past, present and future","volume":"76","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"issue":"Suppl 2","key":"10.1016\/j.neuropharm.2018.07.012_bib3","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.3233\/JAD-2010-100414","article-title":"Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase","volume":"20","author":"Atamna","year":"2010","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib4","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0891-5849(02)00780-3","article-title":"Oxidatively modified proteins in aging and disease","volume":"32","author":"Beal","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03033786","article-title":"Neuroprotective and neurorestorative strategies for neuronal injury","volume":"2","author":"Beal","year":"2000","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1113\/jphysiol.2013.257527","article-title":"Calcium regulation of neural rhythms, memory and Alzheimer's disease","volume":"592","author":"Berridge","year":"2014","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib7","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bbamcr.2016.10.023","article-title":"Phospholipids and calmodulin modulate the inhibition of PMCA activity by tau","volume":"1864","author":"Berrocal","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1096\/fj.08-121459","article-title":"Altered Ca2+ dependence of synaptosomal plasma membrane Ca2+-ATPase in human brain affected by Alzheimer's disease","volume":"23","author":"Berrocal","year":"2009","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.bbadis.2012.02.013","article-title":"Calmodulin antagonizes amyloid-beta peptides-mediated inhibition of brain plasma membrane Ca2+-ATPase","volume":"1822","author":"Berrocal","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tins.2008.06.005","article-title":"Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease","volume":"31","author":"Bezprozvanny","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00441-014-1798-8","article-title":"Network-wide dysregulation of calcium homeostasis in Alzheimer's disease","volume":"357","author":"Brawek","year":"2014","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00032.2008","article-title":"Calcium pumps in health and disease","volume":"89","author":"Brini","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib14","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.bbrc.2016.07.117","article-title":"The plasma membrane calcium pumps: focus on the role in (neuro)pathology","volume":"483","author":"Brini","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.bbrc.2017.03.151","article-title":"High affinity binding of amyloid beta-peptide to calmodulin: structural and functional implications","volume":"486","author":"Corbacho","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.pep.2015.12.011","article-title":"An improved method for expression and purification of functional human Ca2+ transporter PMCA4b in Saccharomyces cerevisiae","volume":"120","author":"Corbacho","year":"2016","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib17","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1074\/jbc.274.33.23223","article-title":"Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion","volume":"274","author":"Cherny","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib18","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"De Felice","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib19","doi-asserted-by":"crossref","first-page":"17294","DOI":"10.1074\/jbc.M500997200","article-title":"Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers","volume":"280","author":"Demuro","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.abb.2008.02.026","article-title":"The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation","volume":"476","author":"Di Leva","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0026-895X(25)10091-6","article-title":"Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance","volume":"35","author":"Ford","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/0970-9185.74599","article-title":"Methylene blue: revisited","volume":"26","author":"Ginimuge","year":"2010","journal-title":"J.\u00a0Anaesthesiol. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib23","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1074\/jbc.274.3.1667","article-title":"The expression of plasma membrane Ca2+ pump isoforms in cerebellar granule neurons is modulated by Ca2+","volume":"274","author":"Guerini","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib24","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nm0908-894","article-title":"Hope in Alzheimer's fight emerges from unexpected places","volume":"14","author":"Gura","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib25","first-page":"648","article-title":"Alzheimer disease: the new agenda","volume":"50","author":"Hardy","year":"1992","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/bms.1200070507","article-title":"Vinyldimethylsilyl ethers as derivatives for the characterization of steroids and cannabinoids by gas chromatography mass spectrometry","volume":"7","author":"Harvey","year":"1980","journal-title":"Biomed. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib27","doi-asserted-by":"crossref","first-page":"27916","DOI":"10.1074\/jbc.M602061200","article-title":"Acceleration of amyloid beta-peptide aggregation by physiological concentrations of calcium","volume":"281","author":"Isaacs","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1734-1140(12)70726-0","article-title":"Chemical structure of phenothiazines and their biological activity","volume":"64","author":"Jaszczyszyn","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib29","first-page":"178","article-title":"Dyes, antipsychotic drugs, and antimicrobial activity. Fragments of a development, with special reference to the influence of Paul Ehrlich","volume":"36","author":"Kristiansen","year":"1989","journal-title":"Dan. Med. Bull."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib30","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1096\/fj.04-2549fje","article-title":"Plasma membrane calcium ATPase deficiency causes neuronal pathology in the spinal cord: a potential mechanism for neurodegeneration in multiple sclerosis and spinal cord injury","volume":"19","author":"Kurnellas","year":"2005","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nrn960","article-title":"Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease","volume":"3","author":"LaFerla","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib32","series-title":"Principles of Fluorescence Spectroscopy","author":"Lakowicz","year":"2006"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.neurobiolaging.2014.10.020","article-title":"Abeta42 oligomers selectively disrupt neuronal calcium release","volume":"36","author":"Lazzari","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib34","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1038\/s41598-017-07581-2","article-title":"Shedding light on Alzheimer's beta-amyloidosis: photosensitized methylene blue inhibits self-assembly of beta-amyloid peptides and disintegrates their aggregates","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib66","article-title":"Methylene blue as a cerebral metabolic and hemodynamic enhancer","volume":"7","author":"Lin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1471-2202-10-112","article-title":"Ontogeny of ATP hydrolysis and isoform expression of the plasma membrane Ca2+-ATPase in mouse brain","volume":"10","author":"Marcos","year":"2009","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2017.08.004","article-title":"Functional interplay between plasma membrane Ca2+-ATPase, amyloid beta-peptide and tau","volume":"663","author":"Mata","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib37","doi-asserted-by":"crossref","first-page":"30303","DOI":"10.1074\/jbc.M114.568212","article-title":"Methylene blue modulates beta-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice","volume":"289","author":"Mori","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib38","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1021\/bi700411k","article-title":"Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization","volume":"46","author":"Necula","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-5-45","article-title":"Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden","volume":"5","author":"O'Leary","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/10520296809115068","article-title":"Supravital staining of mammalian brain with intra-arterial methylene blue followed by pressurized oxygen","volume":"43","author":"O'Leary","year":"1968","journal-title":"Stain Technol."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/med.20177","article-title":"Cellular and molecular actions of Methylene Blue in the nervous system","volume":"31","author":"Oz","year":"2011","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib42","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bcp.2009.04.034","article-title":"Methylene blue and Alzheimer's disease","volume":"78","author":"Oz","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.neuropharm.2018.07.012_bib43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2013.06.033","article-title":"Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model","volume":"76","author":"Paban","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib44","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.bbamcr.2015.12.011","article-title":"Multifaceted plasma membrane Ca2+ pumps: from structure to intracellular Ca2+ handling and cancer","volume":"1863","author":"Padanyi","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/qsar.19970160102","article-title":"QSAR and molecular modelling of catamphiphilic drugs able to modulate multidrug resistance in tumors","volume":"16","author":"Pajeva","year":"1997","journal-title":"Quant. Struct.-Act. Relat."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01203070","article-title":"Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability","volume":"122","author":"Pajeva","year":"1996","journal-title":"J.\u00a0Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib47","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/bi0359473","article-title":"Ca2+ transport by the synaptosomal plasma membrane Ca2+-ATPase and the effect of thioridazine","volume":"43","author":"Palacios","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib48","doi-asserted-by":"crossref","first-page":"3245935","DOI":"10.1155\/2016\/3245935","article-title":"Tau-centric targets and drugs in clinical development for the treatment of Alzheimer's disease","volume":"2016","author":"Panza","year":"2016","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib49","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002280000124","article-title":"Pharmacokinetics and organ distribution of intravenous and oral methylene blue","volume":"56","author":"Peter","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib50","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1046\/j.1471-4159.2003.02227.x","article-title":"Intraneuronal amyloid-beta1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death","volume":"88","author":"Pierrot","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib51","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2016.09.053","article-title":"Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - a therapeutic opportunity?","volume":"483","author":"Popugaeva","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00686306","article-title":"Reversal of multidrug resistance by phenothiazines and structurally related compounds","volume":"30","author":"Ramu","year":"1992","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib54","doi-asserted-by":"crossref","first-page":"571S","DOI":"10.1042\/bst023571s","article-title":"Identification of two types of Ca2+ transport ATPases in pig brain by specific antibodies","volume":"23","author":"Salvador","year":"1995","journal-title":"Biochem. Soc. Trans."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2018.07.012_bib55","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/bj3150183","article-title":"Purification of the synaptosomal plasma membrane (Ca2+\u00a0+ Mg2+)-ATPase from pig brain","volume":"315","author":"Salvador","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib56","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1471-4159.2007.04794.x","article-title":"Functional and immunocytochemical evidence for the expression and localization of the secretory pathway Ca2+-ATPase isoform 1 (SPCA1) in cerebellum relative to other Ca2+ pumps","volume":"103","author":"Sepulveda","year":"2007","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib57","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1471-4159.2005.03401.x","article-title":"A\u00a0developmental profile of the levels of calcium pumps in chick cerebellum","volume":"95","author":"Sepulveda","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1586\/14737175.2016.1140039","article-title":"Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium","volume":"16","author":"Seripa","year":"2016","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ceca.2009.12.014","article-title":"The dysregulation of intracellular calcium in Alzheimer disease","volume":"47","author":"Supnet","year":"2010","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib61","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib62","doi-asserted-by":"crossref","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","article-title":"Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates","volume":"274","author":"Walsh","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2018.07.012_bib63","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/JAD-170560","article-title":"Potential of low dose leuco-methylthioninium bis(hydromethanesulphonate) (LMTM) monotherapy for treatment of mild Alzheimer's disease: cohort analysis as modified primary outcome in a phase III clinical trial","volume":"61","author":"Wilcock","year":"2018","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib64","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease","volume":"44","author":"Wischik","year":"2015","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.neuropharm.2018.07.012_bib65","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s12035-014-9088-8","article-title":"Methylene blue improves brain mitochondrial ABAD functions and decreases abeta in a neuroinflammatory Alzheimer's disease mouse model","volume":"53","author":"Zakaria","year":"2016","journal-title":"Mol. Neurobiol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818303691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T17:28:48Z","timestamp":1751736528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818303691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":65,"alternative-id":["S0028390818303691"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methylene blue activates the PMCA activity and cross-interacts with amyloid \u03b2-peptide, blocking A\u03b2-mediated PMCA inhibition","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}